Navigation Links
CMS Proposes Permanent Medicare Payment for VisionCare's Telescope Implant for Macular Degeneration
Date:7/9/2013

SARATOGA, Calif., July 9, 2013 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., today announced the Centers for Medicare and Medicaid Services (CMS) has proposed to provide reimbursement for VisionCare's Implantable Miniature Telescope (by Dr. Isaac Lipshitz), the first FDA-approved ophthalmic telescope implant indicated to improve vision in patients with end-stage age-related macular degeneration (AMD), in 2014. The announcement was included as part of CMS' CY 2014 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgery Center (ASC) Payment System proposed rule.

According to the proposal, CMS would assign the telescope implant procedure (CPT® code* 0308T) to a new Ambulatory Payment Classification (APC) 0351, Level VII Anterior Segment Eye Procedures, with mean cost calculated using claims data available for the final rule. If finalized, the new APC would be effective January 1, 2014.

"We are encouraged by CMS' proposal to create a new clinical APC for the telescope implant procedure beginning in January 2014 to solidify patient access," said Allen W. Hill, CEO of VisionCare, "Over the course of the last year, VisionCare has provided important data to CMS on the cost and use of the device to treat patients with severe vision loss due to end-stage AMD." 

At present, the telescope implant procedure is reimbursed under a transitional pass-through payment mechanism that will expire on December 31, 2013.  VisionCare is continuing to analyze this proposal and intends to submit comments to CMS as part of the rate-setting process.

About the CentraSight Treatment Program

The first-of-kind telescope implant is integral to a new patient care program, CentraSight, for patients with end-stage macular degeneration. The CentraSight treatment program involves a patient management process and access to reimbursement information for patients and physicians. The telescope implantation is performed by a specially trained ophthalmic surgeon as an outpatient procedure.

Patients and physicians can find more information about the telescope implant and related treatment program at www.CentraSight.com or 1-877-99-SIGHT.

About the Telescope Implant

The Implantable Miniature Telescope (by Dr. Isaac Lipshitz) is indicated for monocular implantation to improve vision in patients greater than or equal to 75 years of age with stable severe to profound vision impairment (best-corrected distance visual acuity 20/160 to 20/800) caused by bilateral central scotomas (blind areas) associated with end-stage AMD. This level of visual impairment constitutes statutory (legal) blindness. Smaller than a pea, the telescope is implanted in one eye in an outpatient surgical procedure. In the implanted eye, the device renders enlarged central vision images over a wide area of the retina to improve central vision, while the non-operated eye provides peripheral vision for mobility and orientation.

The risks and benefits associated with the telescope implant are discussed in the Patient Information Booklet available at www.CentraSight.com.

About VisionCare

VisionCare Ophthalmic Technologies, Inc., headquartered in Saratoga, CA, is a privately-held company focused on development, manufacturing, and marketing of implantable ophthalmic devices and technologies that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. VisionCare's Implantable Miniature Telescope was invented by company founders Yossi Gross and Isaac Lipshitz. Information on VisionCare can be found at www.visioncareinc.net.

*CPT copyright 2013 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.


'/>"/>
SOURCE VisionCare Ophthalmic Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Proposes Unique Device Identification Regulations for Medical Devices
2. Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine
3. Kaiser Permanente Study Finds Varied Reasons Why Patients Do Not Fill their Initial Statin Prescriptions
4. Nearly 30 Percent of Women Fail to Pick Up New Prescriptions for Osteoporosis, Kaiser Permanente Study Finds
5. Doug Bonacum of Kaiser Permanente Named to List of 50 Experts Leading the Field of Patient Safety
6. Kaiser Permanente Receives Award for Excellence in Medication Safety
7. Kaiser Permanente Members Share Stories of Survival for Februarys Heart Health Month
8. Jack Cochran, MD, Executive Director of The Permanente Federation at Kaiser Permanente, named to National Quality Forum Board
9. Kaiser Permanente Joins Rock Health to Support Digital Innovation in Health Care
10. Kaiser Permanente Appoints Alexandra Morehouse as Vice President of Advertising and Brand Management
11. Four Million People Choose Connectivity and Convenience with Kaiser Permanentes Personal Health Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2020)... (PRWEB) , ... August 04, 2020 , ... Fifty six ... to respond more quickly and effectively to a healthcare crisis like COVID-19, according to ... is one of the most important issues for older voters this year,” says Mary ...
(Date:8/5/2020)... ... August 05, 2020 , ... ... , Best Practices During COVID-19, An FDAnews Webinar, Wednesday, Aug. 19, 2020, ... a controlled cleanroom is never simple and COVID-19 has made it more ...
(Date:8/3/2020)... ... August 03, 2020 , ... Seattle’s Infectious ... to amend and restate IDRI’s license with Immune Design, a wholly owned subsidiary ... the amendment, the parties have agreed to modify the licensed fields and indications ...
Breaking Medicine Technology:
(Date:8/5/2020)... ... August 05, 2020 , ... Atlanta Magazine partnered with Castle ... the “Top Doctor” survey. The mission of Castle Connolly Medical Ltd. is to ... and key medical leaders were asked to identify outstanding doctors in their respective ...
(Date:8/5/2020)... ... August 05, 2020 , ... Hypoglycemia (low ... prolonged length of hospital stay, or even death. A researcher at the VA ... Type 2 diabetes to see if the use of continuous glucose monitoring devices ...
(Date:8/5/2020)... ... August 05, 2020 , ... CentrAlert, Inc. today announced the ... to essential COVID-19 information. Know NOW!, which is available for Apple and ... them in one easy-to-use mobile application. , “When COVID-19 first hit, there was so ...
(Date:8/5/2020)... Texas (PRWEB) , ... August 04, 2020 , ... ... older adults living with memory impairment, has announced the Best Memory Care Facilities ... access to experts, facility features and amenities. , According to the ...
(Date:8/3/2020)... , ... August 03, 2020 , ... ... the launch of its newest product, CoverageCoach. The site provides a simple and ... purchase insurance products. The company sees CoverageCoach as an important expansion for the ...
Breaking Medicine News(10 mins):